Taplitumomab paptox

From WikiMD's Wellness Encyclopedia

Taplitumomab paptox is a monoclonal antibody that was developed for the treatment of cancer. It is also known by its developmental code name, B43.13.

History[edit | edit source]

Taplitumomab paptox was developed by the Immunogen Inc., a biotechnology company specializing in antibody-drug conjugates for the treatment of cancer. The drug was designed to target the CD22 antigen, a protein found on the surface of B cells, which are often involved in certain types of lymphoma and leukemia.

Mechanism of Action[edit | edit source]

Taplitumomab paptox is a monoclonal antibody conjugated to a toxin, hence the "paptox" in its name. The antibody portion of the drug binds to the CD22 antigen on the surface of B cells. Once bound, the drug is internalized by the cell, where the toxin is released. The toxin then interferes with protein synthesis, leading to cell death.

Clinical Trials[edit | edit source]

Taplitumomab paptox underwent Phase I and II clinical trials for the treatment of non-Hodgkin's lymphoma and B-cell acute lymphoblastic leukemia. However, the drug did not progress to Phase III trials, and its development was discontinued.

See Also[edit | edit source]

References[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD